October 25, 2007 - Global Therapeutics, a Cook Medical company, said at TCT 2007 it will begin a clinical trial using ...
October 24, 2007 – During a live demonstration at TCT 2007 of CoreValve’s 18-French ReValving System for percutaneous ...
October 25, 2007 - Terumo Interventional Systems announced at TCT 2007 the launch of the TR Band, a radial artery compression device designed to safely and comfortably stop bleeding after transradial procedures, designed to allow the clinician to easily check for clotting and to promote greater patient comfort.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
October 24, 2007 – St. Jude Medical took the stage at TCT 2007 to introduce its new hybrid carotid guiding sheath ...
October 25, 2007 - GE Healthcare displayed its SnapShot Pulse technology designed to maintain high computed tomography ...
October 25, 2007 – Siemens highlighted at TCT 2007 the syngo DynaCT Cardiac solution, a planning tool that enables cross ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
October 24, 2007 – ev3 Inc. highlighted at TCT 2007 its merger with FoxHollow Technologies, Inc., which created an organization that possesses one of the largest U.S. distribution footprints in endovascular devices with combined technologies for the advancement of the treatment of peripheral and neurovascular disease.
October 23, 2007 - ENDEAVOR IV reached its primary endpoint of target vessel failure non-inferiority when compared to ...
OCTOBER 23, 2007 – Abbott’s fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 23, 2007 - PLC Systems Inc. introduced at TCT 2007 the RenalGuard System, an investigational system and therapy ...
October 23, 2007 - Hologic Inc.
October 23, 2007 – Patients who received the CYPHER Sirolimus-eluting coronary stent had a lower risk of stent ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 22, 2007 – A time-motion study conducted at Providence Heart Institute in Columbia, SC, spanning approximately ...
October 22, 2007 – At TCT 2007, ProSolv CardioVascular, a FUJIFILM company, (ProSolv) demonstrated its advanced ...
October 23, 2007 – After 12 months of the SPIRIT III trial, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the original vessel blockage after using a Xience V everolimus-eluting coronary stent than a Taxus paclitaxel-eluting stent, researchers reported at TCT 2007.
October 24, 2007
